24 June 2024
HealthTech Super Connector: Coulter Partners connects the ecosystem in London
The idea was simple: bring together the passionate individuals shaping London's HealthTech ecosystem for a collaborative "super connection" during London Tech Week. With over 200 attendees registered, the inaugural HealthTech Super Connector event did just that, fostering valuable connections and closing the innovation gap in this dynamic field.
The event attracted a diverse group of participants, with 70% representing start-up and scale-up HealthTech companies. The remaining attendees comprised a powerful mix of tier-one investors, potential customers (NHS, Pharma, MedTech, and Tech), and industry influencers. This curated environment facilitated meaningful interactions between innovators and investors, bridging the critical gap that can hinder progress.
The Super Connector wasn't just about forging new connections; it was also about showcasing the incredible talent driving the HealthTech revolution. In the lead-up to the event, a selection of participating start-up and scale-up companies were profiled, highlighting the diverse range of ground-breaking solutions being developed:
Amber Vodegel, 28X // Kelly Klifa and Alexandra (Sasha) T., Ally Health // Dr Chen Mao Davies, Anya // Will Goddard, Big Health // Tim Routledge, Biostress // Richard Chambers, ChamberTech // Lucy Jung, Charco // Benyamin Deldar, Deep Medical // Craig Coulton, GeneHub // Sam Milliken-Smith, Hibi // Michael Ebner, Hypervision Surgical // Luis Valente, ILOF // Kate Newhouse, CMgr CCMI, Kooth // Jack Francis, Pogo Studio // Achala de Mel, NuTissu Ltd //Piyush Mahapatra, Open Medical // Kelly McCabe and Morgan Fitzsimons, Perci Health // Steve Roest, PocDoc // Nelson Jordan, Praxium AI // Zoe Wright, The Real Birth Company Limited // Zaid Al-fagih, MD, Rhazes AI // Chris Dial, Salutare // Kimberly Jane L., Solace Space // Huw Penson, SomX // Andrew Grace, TCEB // Sonia Kaurah, Tala Thrive // Ameera Patel, Tidal Sense // Dr Priya Sadhwani, Ufonia // Maria Marinova, PhD, VitaDAO // David Laith Rawaf, MD, VitVio // Frances A., WHYZE Health
A Super Collaboration
The success of the event wouldn't have been possible without the incredible support of our partners: Amazon Web Services (AWS) // HSBC Innovation Banking // Wolff Olins // HLTH Europe // NHS Innovation Accelerator // AlbionVC // Wilson Sonsini Goodrich & Rosati. London Institute for Healthcare Engineering generously provided a fantastic venue with breath taking views of the Thames.
Additionally, a prestigious roster of venture capital firms and investment groups, including AlbionVC // Antler // Atomico // Bethnal Green Ventures // BGF // Calm/Storm // Cambridge Angels // CGE Partners //Eka Ventures // EQT Group // Freya Ventures // Frog Capital // Frontline Ventures // GHO Capital Partners LLP // Gresham House Ventures // Guinness Ventures // Hambro Perks // Heal Capital // Hummingbird Ventures // InHealth Ventures // Innovis VC // Kinnevik // KHP Ventures // LBO France // MassMutual // Mercia Ventures // Molten Ventures // Monograph Capital // Notion Capital // Octopus Ventures // Openseed VC // Oxford Science Enterprises // PROfounders Capital // Softbank Venture Capital // Speedinvest // Stride.VC // Synova // ZINC joined the event, demonstrating their commitment to fostering innovation in HealthTech.
Beyond the Event
The energy and positive feedback from the Super Connector suggest a successful first edition. With a mix of 150 attendees, lively discussions, and even a surprise baby guest, the event fostered a truly collaborative environment.
Stay tuned for updates on the potential for a second HealthTech Super Connector this autumn, and Coulter Partners' continued endeavors to connect and empower the HealthTech community!
Related
-
Events
LSX Inv€$tival Showcase
18 November 2024
-
Company News
Coulter Partners hosts inaugural annual partners meeting
17 October 2024
-
Company News
HLTH Europe: the Coulter Partners team takes on Amsterdam
27 June 2024
-
Company News
Chris Palatucci featured in STAT News
25 January 2024 | Author: Dr Chris Palatucci (PhD)